Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-03-25

Clinical Trial Update: Seroquel® Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Seroquel (quetiapine) combined with cognitive remediation therapy added to conventional treatment in patients with schizophr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SEROQUEL (QUETIAPINE)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED